Biological perspectives: Drugs used for cognitive symptoms of Alzheimer's disease

Perspectives in Psychiatric Care, Jan-Mar 2001 by Keltner, Norman L, Zielinski, Angela L, Hardin, M Sloan

References

Alagiakrishnan, K., Wong, W., & Blanchette, P.L. (2000). Use of donepezil in elderly patients with Alzheimer's disease-A Hawaii based study. Hawaii Medical Journal, 59,57-59.

Geldmacher, D.S. (1997). Donepezil (Aricept) therapy for Alzheimer's disease. Comprehensive Therapy, 23,492-493.

Keltner, N.L. (1994). Tacrine: A pharmacological approach to Alzheimer's disease. Journal of Psychosocial Nursing and Mental Health Services, 320, 37-39.

Keltner, N.L., & Folks, D.G. (2001). Psychotropic drugs Ord ed.). Philadelphia: Harcourt Health Sciences.

Nordberg, A., & Svensson, A. (1998). Cholinesterase inhibitors in the treatment of Alzheimer's disease. Drug Experience, 19, 465-480.

Purves, D., Augustine, G.J., Fitzpatrick, D., Katz, L.C., LaMantia, A.S., & McNamara, J.0. (1997). Neuroscience. Sunderland, MA: Sinauer Associates.

Raskind, M.A., Peskind, E.R., Wessel, T., & Yuan, W. (2000). Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. Neurology, 54, 2261-2268.

Rogers, S.L., Doody, R.S., Mohs, R.C., & Friedhoff, L.T. (1998). Donepezil improves cognition and global function in Alzheimer's disease. Archives of Internal Medicine, 158,1021-1031.

Ross, J.S., & Shua-Haim, JR. (1998). Aricept-induced nightmares in Alzheimer's disease: 2 case reports (letter). Journal of the American Geriatric Society, 46, 119-120.

Samuels, S.C., & Davis, K.L. (1997). A risk-benefit assessment of tacrine in the treatment of Alzheimer's disease. Drug Safety, 16, 66-77.

Summers, W.K., Majovski, LN., Marsh, G.M., Tachiki, K, & Kling, A. (1986). Oral tetrahydroanfoacridine in long-term treatment of senile dementia, Alzheimer type. New England Journal of Medicine, 315, 1241-1245.

Tariot, P.N., Solomon, P.R., Morris, J.C., Kershaw, P., Lilienfeld, S., & Ding, C. (2000). A 5-month, randomized, placebo-controlled trial of galantamine in AD. Neurology, 54, 2269-2276.

Terpstra, T., & Terpstra, T. (1998). Treating Alzheimer's disease with cholinergic drugs, Part 1. Nurse Practitioner, 23, 90-102.

Search terms: Alzheimer's disease, donepezil, galantamine, rivastigmine, tacrine

Thank you!

We would like to thank the following people

who, in addition to members of the Editorial Board, reviewed manuscripts in 2000:

Kari Winters, Sherman Oaks, CA Lois Whidly, Orange, CA

Cheryl St. George, Pasadena, CA

Teresa Steele, Husson College, Bangor, ME Helanie Shimei, Montrose, NY

Marie McQueen, Anchorage, AL

Barbara Reynolds Caldwell, Springfield, VA

Norman L. Keltner, EdD, RN

Professor, University of Alabama School of Nursing

Angela L. Zielinski, BSN, RN

Brookwood Medical Center, Birmingham

M. Sloan Hardin, SN

University of Alabama at Birmingham School of Nursing

Author contact: keltnern@son.uab.edu, with a copy to the Editor: mary77@concentric.net

Copyright Nursecom, Inc. Jan-Mar 2001
Provided by ProQuest Information and Learning Company. All rights Reserved

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here

Content provided in partnership with ProQuest